IBEX Limited financials
$43.38−2.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Jun 30 | FY25 Jun 30 | FY24 Jun 30 | FY23 Jun 30 | FY22 Jun 30 | FY21 Jun 30 |
|---|---|---|---|---|---|---|
| Revenue | $644.1M | $558.3M | $508.6M | $523.1M | $492.9M | $443.4M |
| Gross profit | $187.9M | $172.6M | $152.0M | $148.1M | $118.9M | $108.1M |
| Gross margin | 29.2% | 30.9% | 29.9% | 28.3% | 24.1% | 24.4% |
| Operating income | $55.0M | $46.6M | $39.4M | $40.5M | $20.6M | $17.0M |
| Net income | $46.3M | $36.9M | $33.7M | $31.6M | $21.5M | $13.1M |
| Net margin | 7.2% | 6.6% | 6.6% | 6.0% | 4.4% | 3.0% |
| Diluted EPS | $3.13 | $2.34 | $1.84 | $1.67 | $1.15 | $0.71 |
| EBITDA | $74.9M | $63.8M | $58.9M | $59.5M | $38.7M | $43.1M |
| Operating cash flow | $59.0M | $45.7M | $35.9M | $41.9M | $40.0M | $16.1M |
| Free cash flow | $31.2M | $27.3M | $27.0M | $22.9M | $14.1M | -$4.7M |
| Diluted shares | 14.8M | 15.7M | 18.3M | 18.9M | 18.7M | 18.4M |
Balance sheet
| Period end | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|
| Cash & equivalents | $32.6M | $15.3M | $62.7M | $57.4M | $48.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $1.7M | $1.6M | $1.5M | $1.0M | $15.7M |
| Total assets | $309.1M | $273.2M | $293.9M | $293.3M | $294.2M |
| Total liabilities | $138.9M | $138.9M | $128.1M | $143.4M | $180.7M |
| Shareholders' equity | $170.2M | $134.3M | $165.8M | $150.0M | $113.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology